Show simple item record

dc.contributor.authorMcWilliams, L.
dc.contributor.authorEvans, D Gareth R
dc.contributor.authorPayne, K.
dc.contributor.authorHarrison, F.
dc.contributor.authorHowell, Anthony
dc.contributor.authorHowell, Sacha J
dc.contributor.authorFrench, David P
dc.date.accessioned2022-10-26T12:58:58Z
dc.date.available2022-10-26T12:58:58Z
dc.date.issued2022en
dc.identifier.citationMcWilliams L, Evans DG, Payne K, Harrison F, Howell A, Howell SJ, et al. Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting. Cancers (Basel). 2022 Sep 24;14(19). PubMed PMID: 36230559. Pubmed Central PMCID: PMC9563640. Epub 2022/10/15. eng.en
dc.identifier.pmid36230559en
dc.identifier.doi10.3390/cancers14194636en
dc.identifier.urihttp://hdl.handle.net/10541/625718
dc.description.abstractIt is now possible to accurately assess breast cancer risk at routine NHS Breast Screening Programme (NHSBSP) appointments, provide risk feedback and offer risk management strategies to women at higher risk. These strategies include National Institute for Health and Care Excellence (NICE) approved additional breast screening and risk-reducing medication. However, the NHSBSP invites nearly all women three-yearly, regardless of risk. In March 2022, a one-day agenda setting meeting took place in Manchester to discuss the feasibility and desirability of implementation of risk-stratified screening in the NHSBSP. Fifty-eight individuals participated (38 face-to-face, 20 virtual) with relevant expertise from academic, clinical and/or policy-making perspectives. Key findings were presented from the PROCAS2 NIHR programme grant regarding feasibility of risk-stratified screening in the NHSBSP. Participants discussed key uncertainties in seven groups, followed by a plenary session. Discussions were audio-recorded and thematically analysed to produce descriptive themes. Five themes were developed: (i) risk and health economic modelling; (ii) health inequalities and communication with women; (iii); extending screening intervals for low-risk women; (iv) integration with existing NHSBSP; and (v) potential new service models. Most attendees expected some form of risk-stratified breast screening to be implemented in England and collectively identified key issues to be resolved to facilitate this.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.3390/cancers14194636en
dc.titleImplementing risk-stratified breast screening in England: an agenda setting meetingen
dc.typeArticleen
dc.contributor.departmentManchester Centre for Health Psychology, Division of Psychology & Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester M13 9PL, UKen
dc.identifier.journalCancersen
dc.description.noteen]
refterms.dateFOA2022-11-01T13:41:01Z


Files in this item

Thumbnail
Name:
36230559.pdf
Size:
324.6Kb
Format:
PDF
Description:
Identified with Open Access button

This item appears in the following Collection(s)

Show simple item record